JWT Lands Global Drug Business

J. Walter Thompson last week won creative duties outside the U.S. on an unnamed new incontinence drug to be co-marketed by Boehringer Ingelheim and Eli Lilly & Co., sources said. The other finalists for the estimated $25 million assignment were Omnicom’s BBDO in Dusseldorf, Germany; IPG’s Foote Cone & Belding in New York; and Havas’ Euro RSCG Life in London, said sources. JWT’s London office will likely manage the account.